Shu Liming, Liang Jiahui, Xun Weiquan, Yang Hong, Lu Tao
Department of Neurology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
Department of Neurology and Stroke Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Front Neurol. 2020 Apr 16;11:268. doi: 10.3389/fneur.2020.00268. eCollection 2020.
The association of retinal microvascular abnormalities with the total cerebral small vessel disease (cSVD) burden found on brain MRI has not been determined. In the present study, we examined whether the retinopathy score could predict the total cSVD burden in ischemic stroke/transient ischemic attack (TIA) patients. A simple practical diagnostic tool may help identify candidates for MRI screening. We consecutively collected clinical data including retinal photography and cerebral MRI of ischemic stroke/TIA patients from August 2016 to August 2017 at our stroke center. The retinopathy score was assessed by the Keith-Wagener-Barker grading system for analyzing retinal microvascular abnormalities. To evaluate the total cSVD burden, the total cSVD score was assessed by awarding one point for the presence of each marker of cSVD on MRI. The clinical characteristics and retinopathy score were analyzed across patients for each total cSVD score. The association between the retinopathy score and the total cSVD score was analyzed. Among the 263 enrolled patients, the frequency of hypertension in patients with a total cSVD score of 2, 3, or 4 was higher than that in patients with a score of 0 (69.5, 71.7, and 89.2% vs. 45.2% respectively, all < 0.05). The retinopathy score was related to the total cSVD score ( = 0.687, < 0.001). Adjusted multivariate ordinal regression showed that the retinopathy score was independently correlated with the total cSVD score (odds ratio [OR], 4.18; 95% confidence interval [CI], 3.07-5.70) after adjustment for age, history of hypertension, previous stroke/TIA and current smoking. The c statistics were 0.30 (95% CI, 0.24-0.37; < 0.05), 0.46 (95% CI, 0.39-0.53; = 0.303), 0.79 (95% CI, 0.72-0.86; < 0.001), and 0.81 (95% CI, 0.74-0.88; < 0.001) for predicting the total cSVD score of 1, 2, 3, and 4 respectively. These results suggest that retinal microvascular abnormalities have predictive value for severe total cSVD burden in ischemic stroke/TIA patients.
视网膜微血管异常与脑磁共振成像(MRI)上发现的全脑小血管疾病(cSVD)负担之间的关联尚未确定。在本研究中,我们检测了视网膜病变评分是否能够预测缺血性卒中/短暂性脑缺血发作(TIA)患者的全脑cSVD负担。一种简单实用的诊断工具可能有助于识别MRI筛查的候选对象。我们于2016年8月至2017年8月在我们的卒中中心连续收集了缺血性卒中/TIA患者的临床资料,包括视网膜照片和脑部MRI。通过Keith-Wagener-Barker分级系统评估视网膜病变评分,以分析视网膜微血管异常。为了评估全脑cSVD负担,通过对MRI上每个cSVD标志物的存在给予1分来评估全脑cSVD评分。针对每个全脑cSVD评分的患者分析其临床特征和视网膜病变评分。分析视网膜病变评分与全脑cSVD评分之间的关联。在263名纳入研究的患者中,全脑cSVD评分为2、3或4的患者中高血压的发生率高于评分为0的患者(分别为69.5%、71.7%和89.2%对45.2%,均<0.05)。视网膜病变评分与全脑cSVD评分相关(=0.687,<0.001)。校正后的多变量有序回归显示,在调整年龄、高血压病史、既往卒中/TIA和当前吸烟情况后,视网膜病变评分与全脑cSVD评分独立相关(优势比[OR]为4.18;95%置信区间[CI]为3.07 - 5.70)。预测全脑cSVD评分为1、2、3和4时的c统计量分别为0.30(95%CI为0.24 - 0.37;<0.05)、0.46(95%CI为0.39 - 0.53;=0.303)、0.79(95%CI为0.72 - 0.86;<0.001)和0.81(95%CI为0.74 - 0.88;<0.001)。这些结果表明,视网膜微血管异常对缺血性卒中/TIA患者严重的全脑cSVD负担具有预测价值。